Literature DB >> 12055291

Lysophosphatidic acid inhibition of the accumulation of Pseudomonas aeruginosa PAO1 alginate, pyoverdin, elastase and LasA.

David C Laux1, Joy M Corson1, Michael Givskov2, Morten Hentzer2, Annette Møller1, Kathleen A Wosencroft1, Joan C Olson3, Karen A Krogfelt4, Joanna B Goldberg5, Paul S Cohen1.   

Abstract

The pathogenesis of Pseudomonas aeruginosa is at least partially attributable to its ability to synthesize and secrete the siderophore pyoverdin and the two zinc metalloproteases elastase and LasA, and its ability to form biofilms in which bacterial cells are embedded in an alginate matrix. In the present study, a lysophospholipid, 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate [also called monopalmitoylphosphatidic acid (MPPA)], which accumulates in inflammatory exudates, was shown to inhibit the extracellular accumulation of P. aeruginosa PAO1 alginate, elastase, LasA protease and the siderophore pyoverdin. MPPA also inhibited biofilm formation. The inhibitory effects of MPPA occur independently of rpoS expression and without affecting the accumulation of the autoinducers N-(3-oxododecanoyl) homoserine lactone and N-butyryl-L-homoserine lactone, and may be due, at least in part, to the ability of MPPA to bind divalent cations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055291     DOI: 10.1099/00221287-148-6-1709

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  12 in total

1.  Host derived inflammatory phospholipids regulate rahU (PA0122) gene, protein, and biofilm formation in Pseudomonas aeruginosa.

Authors:  Jayasimha Rao; Antonio DiGiandomenico; Mykhaylo Artamonov; Norbert Leitinger; Ashok R Amin; Joanna B Goldberg
Journal:  Cell Immunol       Date:  2011-05-05       Impact factor: 4.868

2.  Impact of alginate-producing Pseudomonas aeruginosa on alveolar macrophage apoptotic cell clearance.

Authors:  Charlie A McCaslin; Daniela N Petrusca; Gregory G Anderson; Irina Petrache; Christophe Poirier; Karina A Serban
Journal:  J Cyst Fibros       Date:  2014-07-12       Impact factor: 5.482

3.  Secretion of Pseudomonas aeruginosa type III cytotoxins is dependent on pseudomonas quinolone signal concentration.

Authors:  G Singh; B Wu; M S Baek; A Camargo; A Nguyen; N A Slusher; R Srinivasan; J P Wiener-Kronish; S V Lynch
Journal:  Microb Pathog       Date:  2010-06-02       Impact factor: 3.738

4.  Development and biological evaluation of fluorophosphonate-modified hydroxyapatite for orthopaedic applications.

Authors:  Gráinne Neary; Ashley W Blom; Anna I Shiel; Gabrielle Wheway; Jason P Mansell
Journal:  J Mater Sci Mater Med       Date:  2018-07-21       Impact factor: 3.896

5.  Efficient production of L-ribose with a recombinant Escherichia coli biocatalyst.

Authors:  Ryan D Woodyer; Nathan J Wymer; F Michael Racine; Shama N Khan; Badal C Saha
Journal:  Appl Environ Microbiol       Date:  2008-03-14       Impact factor: 4.792

6.  Fluorophosphonate-functionalised titanium via a pre-adsorbed alkane phosphonic acid: a novel dual action surface finish for bone regenerative applications.

Authors:  Wayne Nishio Ayre; Tom Scott; Keith Hallam; Ashley W Blom; Stephen Denyer; Heather K Bone; Jason P Mansell
Journal:  J Mater Sci Mater Med       Date:  2015-12-24       Impact factor: 3.896

7.  Calcium and magnesium enhance the production of Pseudomonas aeruginosa protease IV, a corneal virulence factor.

Authors:  Mary E Marquart; Joseph J Dajcs; Armando R Caballero; Brett A Thibodeaux; Richard J O'Callaghan
Journal:  Med Microbiol Immunol       Date:  2003-11-20       Impact factor: 3.402

8.  Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients.

Authors:  Julie Jeukens; Brian Boyle; Irena Kukavica-Ibrulj; Myriam M Ouellet; Shawn D Aaron; Steve J Charette; Joanne L Fothergill; Nicholas P Tucker; Craig Winstanley; Roger C Levesque
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

9.  The Number of Platelets in Patient's Blood Influences the Mechanical and Morphological Properties of PRP-Clot and Lysophosphatidic Acid Quantity in PRP.

Authors:  Michela Bosetti; Paolo Boffano; Alice Marchetti; Massimiliano Leigheb; Mattia Colli; Matteo Brucoli
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

10.  Dual Action of Lysophosphatidate-Functionalised Titanium: Interactions with Human (MG63) Osteoblasts and Methicillin Resistant Staphylococcus aureus.

Authors:  Mette Elena Skindersoe; Karen A Krogfelt; Ashley Blom; Jianxing Zhang; Guowei Jiang; Glenn D Prestwich; Jason Peter Mansell
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.